| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.13.12.1829 |
| P698 | PubMed publication ID | 8241104 |
| P50 | author | Aaron R. Folsom | Q71098091 |
| P2093 | author name string | K K Wu | |
| E Shahar | |||
| C E Davis | |||
| P433 | issue | 12 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 1829-1836 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators | |
| P478 | volume | 13 |
| Q40573006 | A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study |
| Q87140911 | ABO blood group polymorphisms and risk for ischemic stroke and peripheral arterial disease |
| Q73526445 | Activated factor VII levels in patients with angiographically confirmed coronary artery disease |
| Q36120096 | Association of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity |
| Q40702980 | Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities Study |
| Q44518845 | Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia |
| Q43897717 | Cardiovascular risk factors in ethnic minority women aged < or =30 years |
| Q34412711 | Changes in coagulation and fibrinolytic indices in women with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation |
| Q83567841 | Changes in haemostatic and platelet activation markers in non-dipper hypertensive patients |
| Q73250741 | Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin |
| Q42217770 | Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension. |
| Q34451762 | Diabetes mellitus and coronary heart disease |
| Q34107288 | Diet and hemostatic factors |
| Q34106488 | Effects of HMG-CoA reductase inhibitor on hemostasis |
| Q44543186 | Effects of dietary fat quantity and composition on fasting and postprandial levels of coagulation factor VII and serum choline-containing phospholipids |
| Q28373963 | Effects of reserpine on expression of the LDL receptor in liver and on plasma and tissue lipids, low density lipoprotein and fibrinogen in rabbits in vivo |
| Q35213428 | Exercise-induced changes in coagulation and fibrinolysis in healthy populations and patients with cardiovascular disease |
| Q40051287 | Gamma prime (γ') fibrinogen and carotid intima-media thickness: the Atherosclerosis Risk in Communities study |
| Q34186893 | Heart health in older adults. Import of heart disease and opportunities for maintaining cardiac health |
| Q34674022 | Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort |
| Q33798118 | Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women |
| Q36962739 | Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort |
| Q34037922 | Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study |
| Q36783613 | How it all starts: Initiation of the clotting cascade. |
| Q55312862 | Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins. |
| Q73677521 | Impaired ovarian function and risk factors for atherosclerosis in premenopausal women |
| Q51566561 | Increased cardiovascular disease mortality rates in traumatic lower limb amputees. |
| Q33486847 | Inflammation induces fibrinogen nitration in experimental human endotoxemia |
| Q35802242 | Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study |
| Q36191901 | Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application |
| Q35077916 | Levels of haemostatic factors, arteriosclerosis and cardiovascular disease |
| Q35616777 | Low prevalence of significant carotid artery disease in Iranian patients undergoing elective coronary artery bypass. |
| Q37023639 | Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study |
| Q50947214 | Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates |
| Q40458696 | Postmenopausal Hormone-Replacement Therapy and Cardiovascular Risk |
| Q77714696 | Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention |
| Q73378387 | Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin |
| Q59279858 | Relation of leisure-time physical activity to structural and functional arterial properties of the common carotid artery in male subjects |
| Q73022835 | Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude |
| Q44230227 | Risk factors for cryptogenic ischaemic stroke |
| Q43588746 | Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men. |
| Q73531127 | The -323Ins10 polymorphism for factor VII is not associated with coronary atherosclerosis in symptomatic men. The REGRESS study group |
| Q52131991 | The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thromholysis in Myocardial Infarction Phase II (TIMI II) Trial. |
| Q35017821 | The carotid artery as a noninvasive window for cardiovascular risk in apparently healthy individuals |
| Q47438200 | The effect of acute aerobic exercise on hemostasis in obstructive sleep apnea |
| Q36052956 | Thiazolidinediones and cardiovascular disease |
| Q73432501 | [Effect of exercise tolerance test on hemostasis in patients with and without coronary heart disease] |
| Q47098383 | vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease. |
Search more.